Navigation Links
CryoCath to Hold Third Quarter 2008 Conference Call and Webcast
Date:7/30/2008

http://www.cryocath.com

Toronto Stock Exchange Symbol: CYT

MONTREAL, July 30 /PRNewswire-FirstCall/ - CryoCath (TSX: CYT), will hold a conference call to discuss its third quarter 2008 financial results at 9:00 a.m. (Eastern Time) on Tuesday, August 5, 2008. The call will be hosted by Mr. Jan Keltjens, President and CEO and Mrs. Ginette Gagne, CFO. The Company will report its results in a press release to be issued at 7:00 a.m on Tuesday, August 5.

DATE: Tuesday, August 5, 2008

TIME: 9:00 a.m., Eastern Time

DIAL IN NUMBER: 416-644-3427 or 1-866-250-4892

TAPED REPLAY: 416-640-1917 or 1-877-289-8525

REFERENCE NUMBER: 21279395 followed by the number sign

WEBCAST: A live audio webcast of the call will be available

at http://www.cryocath.com. Webcast attendees are welcome

to listen to the conference in real-time or

on-demand at their convenience. The webcast will be

archived for 365 days. Please connect to this

website at least 15 minutes prior to the conference

call to ensure adequate time for any software

download that may be needed to hear the webcast.

A question and answer session will follow, at which time the operator will direct participants as to the correct procedure for submitting questions.

About CryoCath

CryoCath - http://www.cryocath.com - is a medical technology company that leads the world in cryotherapy products to treat cardiac arrhythmias. With a priority focus on providing physicians with a complete solution of catheter products to treat cardiac arrhythmias, CryoCath has multiple products approved in the U.S., across Europe and several ROW countries. The Company is developing additional products to expand its pipeline of products to treat cardiac arrhythmias.

This press release includes "forward-looking statements" that are subject to risks and uncertainties, including with respect to the timing of regulatory trials and their outcome. For information identifying legislative or regulatory, economic, climatic, currency, technological, competitive and other important factors that could cause actual results to differ materially from those anticipated in the forward looking statements, see CryoCath's annual report available at http://www.sedar.com under the heading Risks and Uncertainties in the Management's Discussion and Analysis section.


'/>"/>
SOURCE CryoCath Technologies Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. CryoCath Appoints Vice President, Europe
2. CryoCath Presents at Prestigious Heart Rhythm Society Meeting
3. CryoCath Announces Fiscal 2008 Second Quarter Results
4. CryoCath to Hold Second Quarter 2008 Conference Call and Webcast
5. CryoCath Reports Data Presented at the 74th Annual Meeting of the German Cardiac Society
6. CryoCath Introduces Arctic Front in Australia
7. CryoCath Appoints New Chief Financial Officer
8. CryoCath Technologies notice of annual meeting
9. CryoCath Announces Fiscal 2008 First Quarter Results
10. CryoCath Provides Update on Patent Infringement Lawsuit
11. CryoCath to Hold First Quarter 2008 Conference Call and Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2017)... ... 2017 , ... Patients with missing teeth now have the ... from Dr. Alejandro Kovacs. Dr. Kovacs is a board-certified periodontist and prosthodontist who ... dental implants in Longview, TX. , During traditional dental implant ...
(Date:7/27/2017)... ... 27, 2017 , ... TransPanel Volume 4 is a collection of animating panel ... exclusive features transitions that contain between 2 and 6 animated panels. Change the direction ... menus. TransPanel Volume 4 makes editing easy in Final Cut Pro X. , TransPanel ...
(Date:7/27/2017)... Clara, CA (PRWEB) , ... July 27, 2017 ... ... announces the addition of a secure cloud-based polysomnography (PSG) distributed scoring solution to ... support accelerated diagnostics and sleep care management. The speed and functionality of scoring ...
(Date:7/27/2017)... ... 2017 , ... SSCI, a division of Albany Molecular Research, ... representing a milestone achievement. , As an industry-leading provider of ... served as expert and fact witnesses to assist our clients to perform infringement ...
(Date:7/27/2017)... ... ... Angeles leg of the US movie premier of the Man in the Camo Jacket will ... Davis Theater inside the Grammy Museum Located in downtown Los Angeles in the LA Live ... musician, Mike Peters (of The Alarm), his rise to fame, battle with cancer and inspiring ...
Breaking Medicine News(10 mins):
(Date:7/24/2017)... July 24, 2017  Diplomat Pharmacy, Inc. (NYSE: ... its second quarter 2017 operating results on Monday, August ... to follow at 5:00 p.m. ET. ... to a live broadcast of the conference call by ... participant code 51641230 approximately 15 minutes prior to the ...
(Date:7/20/2017)... 2017  Prime Therapeutics LLC (Prime) released this statement from ... today,s Institute for Clinical and Economic Review,s (ICER) public ... and value of abuse-deterrent formulations (ADF) of opioids. Prime was ... the meeting. "The ... to the use of abuse-deterrent formulations (ADF) in opioids in ...
(Date:7/14/2017)... VEGAS , July 13, 2017 It should ... United States is in the midst of a ... Control , since 1999, the number of overdose deaths from ... "resulting in over half a million dead from 2001 to ... codeine, oxycodone, and hydrocodone has similarly quadrupled, drawing a compelling ...
Breaking Medicine Technology: